SelectScience InterviewsLife Sciences

Discover How LGC Use Serial-Passage Testing on Novel Combination Molecules

26 Jul 2016
Discover How LGC Use Serial-Passage Testing on Novel Combination Molecules

Find out how the Drug Development Services team at LGC measure the resistance development potential of new novel compounds against C. difficile-associated disease (CDAD). Ed Siegwart, Senior Scientist, in the Microbiology department at LGC discusses the benefits of serial-passage testing in drug resistance testing.

About the company

SelectScience logo

SelectScience

Established in July 1998, SelectScience is the fastest way to impartial, expert opinion about the best laboratory equipment and latest techniques.

Other videos from SelectScience

Links